PHASE 2 TRIAL OF 5-FLUOROURACIL (NSC-19893), ADRIAMYCIN (NSC-123127), AND METHOTREXATE (NSC-740) IN LUNG ADENOCARCINOMA

被引：0
作者：
LOWITZ, BB [1 ]
机构：
[1] VET ADM HOSP,DEPT MED,DIV HEMATOL ONCOL,INVEST THERAPEUTICS BRANCH,SEPULVEDA,CA 91343
来源：
CANCER TREATMENT REPORTS | 1976年 / 60卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：623 / 624
页数：2
相关论文
共 8 条
[1]   ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].
BLUM, RH ;
CARTER, SK .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :249-259
[2]  
BONADONNA G, 1969, Tumori, V55, P277
[3]  
CORTES EP, 1974, CANCER, V34, P518, DOI 10.1002/1097-0142(197409)34:3<518::AID-CNCR2820340307>3.0.CO
[4]  
2-P
[5]  
Faulkner S L, 1974, Ann Thorac Surg, V18, P578
[6]  
HILL BT, 1975, P AM ASSOC CANC RES, V16, P11
[7]  
Selawry O S, 1974, Semin Oncol, V1, P259
[8]  
ZELEN M, 1973, CANCER CHEMOTH REP 3, V4, P31
1